6 quick snap count observations from Colts' Week 7 win vs. Chargers

The Colts signed Abdullah from the practice squad to the 53-man roster over the weekend, but with his impact, it doesn't look ...

KEYTRUDA® (pembrolizumab) Demonstrates Long-Term Survival Benefit in Certain Patients With Earlier or Advanced Stages of Non-Small Cell Lung Cancer (NSCLC)

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new long-term data highlighting the sustained survival benefits of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 ...